|
US5446090A
(en)
|
1993-11-12 |
1995-08-29 |
Shearwater Polymers, Inc. |
Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
|
|
US20020064546A1
(en)
|
1996-09-13 |
2002-05-30 |
J. Milton Harris |
Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
|
|
PT1053019E
(pt)
|
1998-01-07 |
2004-04-30 |
Debio Rech Pharma Sa |
Acrilatos de poli(etileno-glicol) heterobifuncional degradaveis e geles e conjugados derivados dos mesmos
|
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
|
US6348558B1
(en)
|
1999-12-10 |
2002-02-19 |
Shearwater Corporation |
Hydrolytically degradable polymers and hydrogels made therefrom
|
|
BR0001870B1
(pt)
|
2000-05-29 |
2014-02-25 |
|
Peptídeo, processo de obtenção de peptídeo, formulação compreendendo peptídeo, método de prevenção de crescimento de parasitas, fungos e bactérias, método para inativar a endotoxina de bactérias gram-negativas
|
|
CN1187449C
(zh)
*
|
2003-06-05 |
2005-02-02 |
中国科学院上海药物研究所 |
可溶性sars病毒3cl蛋白酶的表达和纯化
|
|
ES2586387T3
(es)
|
2003-11-05 |
2016-10-14 |
Dana-Farber Cancer Institute, Inc. |
Péptidos alfa helicoidales adecuados para activar o inhibir la muerte celular
|
|
DK2118123T3
(en)
|
2007-01-31 |
2016-01-25 |
Dana Farber Cancer Inst Inc |
Stabilized p53 peptides and uses thereof
|
|
WO2008106507A2
(en)
|
2007-02-27 |
2008-09-04 |
University Of South Florida |
Mdm2/mdmx inhibitor peptide
|
|
US8592377B2
(en)
|
2007-03-28 |
2013-11-26 |
President And Fellows Of Harvard College |
Stitched polypeptides
|
|
CA2700925C
(en)
|
2007-09-26 |
2016-08-23 |
Dana Farber Cancer Institute |
Methods and compositions for modulating bcl-2 family polypeptides
|
|
EP2247606B1
(en)
*
|
2008-01-23 |
2019-08-21 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for the treatment of viral infections
|
|
US8586707B2
(en)
|
2008-09-16 |
2013-11-19 |
The Research Foundation Of State University Of New York |
Stapled peptides and method of synthesis
|
|
CA2737922A1
(en)
|
2008-09-22 |
2010-03-25 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
BRPI0920899A2
(pt)
|
2008-11-24 |
2016-04-26 |
Aileron Therapeutics Inc |
macrociclos peptidomiméticos com propriedades melhoradas
|
|
EP3549951A3
(en)
|
2008-12-09 |
2019-11-20 |
Dana Farber Cancer Institute, Inc. |
Methods and compositions for specific modulation of mcl-1
|
|
AU2010263056B2
(en)
|
2009-06-18 |
2016-01-07 |
Dana Farber Cancer Institute, Inc. |
Structured viral peptide compositions and methods of use
|
|
AU2010273220B2
(en)
|
2009-07-13 |
2015-10-15 |
President And Fellows Of Harvard College |
Bifunctional stapled polypeptides and uses thereof
|
|
WO2011156524A2
(en)
|
2010-06-08 |
2011-12-15 |
Laura Sheard |
Methods and compositions for targeted protein degradation
|
|
CA2803348A1
(en)
*
|
2010-06-25 |
2012-04-19 |
Purdue Research Foundation |
Pathogen detection
|
|
CA2817568A1
(en)
|
2010-11-12 |
2012-05-18 |
The Salk Institute For Biological Studies Intellectual Property And Tech Nology Transfer |
Cancer therapies and diagnostics
|
|
US9517252B2
(en)
|
2011-09-09 |
2016-12-13 |
Agency For Science, Technology And Research |
p53 activating peptides
|
|
US9408885B2
(en)
|
2011-12-01 |
2016-08-09 |
Vib Vzw |
Combinations of therapeutic agents for treating melanoma
|
|
BR112014020103A2
(pt)
|
2012-02-15 |
2018-10-09 |
Aileron Therapeutics, Inc. |
macrociclos peptidomiméticos
|
|
WO2014052647A2
(en)
|
2012-09-26 |
2014-04-03 |
President And Fellows Of Harvard College |
Proline-locked stapled peptides and uses thereof
|
|
EP2904000A4
(en)
|
2012-10-01 |
2016-04-20 |
Agency Science Tech & Res |
PEPTIDES AND METHOD FOR THE TREATMENT OF CANCER
|
|
KR101616603B1
(ko)
|
2012-10-11 |
2016-04-28 |
서울대학교산학협력단 |
메틸 데그론 펩타이드 및 이를 이용한 단백질 수명 조절 방법
|
|
EP2912463A4
(en)
|
2012-10-25 |
2016-03-23 |
Agency Science Tech & Res |
PROCESS FOR DETERMINING THE RESISTANCE TO MOLECULES FOR THE TARGETING OF PROTEINS
|
|
WO2014065760A1
(en)
|
2012-10-25 |
2014-05-01 |
Agency For Science, Technology And Research |
Methods for determining resistance against molecules targeting proteins
|
|
US9115184B2
(en)
|
2013-03-01 |
2015-08-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Light-inducible system for regulating protein stability
|
|
AU2015320545C1
(en)
*
|
2014-09-24 |
2020-05-14 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and formulations thereof
|
|
US11319344B2
(en)
|
2015-02-13 |
2022-05-03 |
Agency For Science, Technology And Research |
Non-membrane disruptive P53 activating stapled peptides
|
|
US20190076504A1
(en)
|
2016-03-23 |
2019-03-14 |
Dana-Farber Cancer Institute, Inc. |
COMPOSITIONS, ASSAYS, AND METHODS FOR TARGETING HDM2 AND HDMX TO REVERSE THE INHIBITION OF p53 IN PEDIATRIC CANCERS
|
|
US11279734B2
(en)
*
|
2017-12-01 |
2022-03-22 |
Massachusetts Institute Of Technology |
Solution-phase affinity selection of inhibitors from combinatorial peptide libraries
|
|
EP3724216A1
(en)
*
|
2017-12-15 |
2020-10-21 |
Dana Farber Cancer Institute, Inc. |
Stabilized peptide-mediated targeted protein degradation
|
|
JP7297053B2
(ja)
*
|
2018-08-20 |
2023-06-23 |
アルビナス・オペレーションズ・インコーポレイテッド |
神経変性疾患を治療するためのｅ３ユビキチンリガーゼ結合活性を有するキメラ（ｐｒｏｔａｃ）化合物を標的とし、アルファ－シヌクレインタンパク質を標的とするタンパク質分解
|
|
CN110257357A
(zh)
*
|
2019-07-04 |
2019-09-20 |
中国人民解放军军事科学院军事医学研究院 |
MERS-CoV 3CLpro作为去泛素化酶和干扰素抑制剂的用途
|